Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals-Reference-Cited by-同舟云学术

Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals

Published:2006-12-15 Issue:5 Volume:43 Page:509-515
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Markowitz Martin,Morales-Ramirez Javier O,Nguyen Bach-Yen,Kovacs Colin M,Steigbigel Roy T,Cooper David A,Liporace Ralph,Schwartz Robert,Isaacs Robin,Gilde Lucinda R,Wenning Larissa,Zhao Jing,Teppler Hedy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference11 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.;Palella;N Engl J Med,1998

2. Changing patterns of mortality across Europe in patients infected with HIV-1. Eurosida Study Group.;Mocroft;Lancet,1998

3. Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1-a decade of experience.;Shet;J Acquir Immune Defic Syndr,2006

4. HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in Greater Kingston, Jamaica.;Johnson;West Indian Med J,2004

5. HIV integrase structure and function.;Esposito;Adv Virus Res,1999

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Precision Drug Therapy and build pharmacokinetic model in Pregnant Women: PBPK Modeling of Antiviral drugs;2024-07-22

2. Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy;Future Pharmacology;2024-04-10

3. Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy;International Journal of STD & AIDS;2022-12-18

4. Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2022-10

5. Is Routine Therapeutic Drug Monitoring of Anti-Retroviral Agents Warranted in Children Living with HIV?;The Journal of Pediatric Pharmacology and Therapeutics;2022-07-01